Zobrazeno 1 - 10
of 28
pro vyhledávání: '"Koen Vos"'
Autor:
Koen Vos, Jef Deckers, Noël Vandenberghe, Marco Schiltz, Piet Laga, Isaac Berwouts, Koen Beerten, Rik Houthuys, Stephen Louwye, Jasper Verhaegen, Rieko Adriaens, Michiel Dusar, Laurent Wouters
Publikováno v:
GEOLOGICA BELGICA
1. Introduction This paper deals with the Kasterlee Formation in the Belgian Campine area (Antwerp and Limburg) and the transition from the Kasterlee Formation to the underlying Diest Formation and the overlying Mol Formation. Like many lithostratigr
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::acc9a2d22ae0ca3f7a8e0fcbf6fe574f
https://hdl.handle.net/1854/LU-8694514
https://hdl.handle.net/1854/LU-8694514
Autor:
Sabrina Pollastro, Barbera D. C. van Schaik, Niek de Vries, Rogier M Thurlings, Antoine H C van Kampen, Koen Vos, Danielle M. Gerlag, Paul P. Tak, Frank Baas, R.E. Esveldt, Paul L. Klarenbeek, Marieke E. Doorenspleet, Maria J H Boumans
Publikováno v:
Annals of the Rheumatic Diseases, 78, 1339-1345
Annals of the Rheumatic Diseases
Annals of the rheumatic diseases, 78(10), 1339-1345. BMJ Publishing Group
Annals of the Rheumatic Diseases, 78(10), 1339-1345. BMJ PUBLISHING GROUP
Annals of the Rheumatic Diseases, 78, 10, pp. 1339-1345
Annals of the Rheumatic Diseases
Annals of the rheumatic diseases, 78(10), 1339-1345. BMJ Publishing Group
Annals of the Rheumatic Diseases, 78(10), 1339-1345. BMJ PUBLISHING GROUP
Annals of the Rheumatic Diseases, 78, 10, pp. 1339-1345
Objective To gain more insight into the dynamics of lymphocyte depletion and develop new predictors of clinical response to rituximab in rheumatoid arthritis (RA). Methods RNA-based next-generation sequencing was used to analyse the B cell receptor (
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c07040df2d4e72d4807c831e2e8afff2
http://hdl.handle.net/2066/208680
http://hdl.handle.net/2066/208680
Autor:
Paul L. Klarenbeek, Rogier M Thurlings, A. H. C. van Kampen, Marieke E. Doorenspleet, Danielle M. Gerlag, R.E. Esveldt, Koen Vos, Frank Baas, Sabrina Pollastro, P.P. Tak, B D C van Schaik, N. de Vries, Marie Boumans
Publikováno v:
THURSDAY, 14 JUNE 2018.
Background Rituximab (RTX) induces more than 98% depletion of the CD20 +B cells in blood after a single injection, yet 35% to 50% of RA treated patients show a poor response to the therapy1. Despite the identification of many different biomarkers, mo
Autor:
Matthias Laudes, Aart C. Strang, Paul P. Tak, R. Bisoendial, Erik S.G. Stroes, Marc R. Kok, Uwe J. F. Tietge, Ruud S. Kootte, Dominik M. Schulte, Johannes H.M. Levels, Danielle M. Gerlag, Sander W. Tas, N Müller, Geesje M. Dallinga-Thie, Koen Vos
Publikováno v:
Atherosclerosis, 229(1), 174-181. Elsevier Ireland Ltd
ATHEROSCLEROSIS, 229(1), 174-181. ELSEVIER IRELAND LTD
ATHEROSCLEROSIS, 229(1), 174-181. ELSEVIER IRELAND LTD
Objectives: Blocking the interleukin-6 pathway by tocilizumab (TCZ) has been associated with changes in the lipoprotein profile, which could adversely impact cardiovascular (CV) risk in patients with rheumatoid arthritis (RA). In the present study, w
Autor:
Dagmar Scheel-Toellner, Paul P. Tak, Danielle M. Gerlag, Rogier M. Thurlings, Lorraine Yeo, Maria J H Boumans, Koen Vos
Publikováno v:
Annals of the rheumatic diseases, 71(1), 108-113. BMJ Publishing Group
ObjectivesTo examine how rituximab may result in the inhibition of joint destruction in rheumatoid arthritis (RA) patients.MethodsTwenty-eight patients with active RA were treated with rituximab. Radiographs of hands and feet before and 1 year after
Publikováno v:
Arthritis and rheumatism. 63(11):3187-3194
In the last decade, with the implementation of new targeted drugs, the efficacy of the treatment of rheumatoid arthritis (RA) has increased enormously. However, a subset of patients still does not respond to any of the available treatments. At this m
Autor:
Carla A. Wijbrandts, Paul P. Tak, Danielle M. Gerlag, Aeilko H. Zwinderman, Rogier M. Thurlings, Koen Vos
Publikováno v:
Annals of the Rheumatic Diseases
Annals of the rheumatic diseases, 67(7), 917-925. BMJ Publishing Group
Annals of the rheumatic diseases, 67(7), 917-925. BMJ Publishing Group
Objective: To investigate the synovial tissue in patients with rheumatoid arthritis (RA) treated with rituximab and to identify possible predictors of clinical response. Methods: A total of 24 patients with RA underwent synovial biopsy before, 4 and
Autor:
Paul P. Tak, Dirkjan van Schaardenburg, Carla A. Wijbrandts, Rogier M. Thurlings, Danielle M. Gerlag, Koen Vos
Publikováno v:
Arthritis and rheumatism, 56(3), 772-778. John Wiley and Sons Inc.
Objective To study the specific effects of rituximab treatment on the synovium in patients with rheumatoid arthritis (RA) early after initiation of treatment. Methods Seventeen RA patients underwent an arthroscopic synovial biopsy procedure directly
Autor:
E. Zanelli, H. Visser, J. M. W. Hazes, F. C. Breedveld, Willem Verduyn, Koen Vos, Geziena M.Th. Schreuder, I. Speyer
Publikováno v:
Annals of the rheumatic diseases, 61(6), 499-504. BMJ Publishing Group
Objectives: (a) To describe the clinical characteristics of acute sarcoid arthritis and the diagnostic value of its presenting clinical features; (b) to evaluate whether disease onset is seasonal; and (c) to evaluate whether smoking behaviour or the
Autor:
Margriet J. Vervoordeldonk, Paul P. Tak, Danielle M. Gerlag, Robert Landewé, Koen Vos, Caroline J. Aalbers
Publikováno v:
Joint, bone, spine, 82(5), 338-344. Elsevier Masson
There is an increased interest in developing gene therapy approaches for local delivery of therapeutic genes in patients with arthritis. Intra-articular (i.a.) gene delivery, using an adeno-associated virus encoding a TNF soluble receptor, resulted i